Compare Stocks: SMLR, BVS, TNDM, and STAA

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BVS Bioventus	$13.13 -2.4%	$13.70	$6.37 ▼ $15.89	$1.10B	0.64	449,099 shs	362,360 shs
SMLR Semler Scientific	$20.33 -4.9%	$19.24	$14.89 ▼ $50.44	$310.74M	1.32	895,814 shs	1.62 million shs
STAA STAAR Surgical	$22.47 +0.4%	$23.04	$15.59 ▼ $35.87	$1.13B	1.17	1.16 million shs	640,036 shs
TNDM Tandem Diabetes Care	$16.50	$19.58	$12.26 ▼ $29.65	$1.15B	1.66	2.17 million shs	2.19 million shs

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BVS Bioventus	0.00%	-4.92%	-8.57%	+25.29%	+95.68%
SMLR Semler Scientific	0.00%	0.00%	0.00%	0.00%	-34.48%
STAA STAAR Surgical	0.00%	+9.56%	-4.71%	-19.14%	-17.33%
TNDM Tandem Diabetes Care	0.00%	+4.96%	-19.24%	+7.70%	+32.96%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BVS Bioventus	$13.13 -2.4%	$13.70	$6.37 ▼ $15.89	$1.10B	0.64	449,099 shs	362,360 shs
SMLR Semler Scientific	$20.33 -4.9%	$19.24	$14.89 ▼ $50.44	$310.74M	1.32	895,814 shs	1.62 million shs
STAA STAAR Surgical	$22.47 +0.4%	$23.04	$15.59 ▼ $35.87	$1.13B	1.17	1.16 million shs	640,036 shs
TNDM Tandem Diabetes Care	$16.50	$19.58	$12.26 ▼ $29.65	$1.15B	1.66	2.17 million shs	2.19 million shs

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BVS Bioventus	0.00%	-4.92%	-8.57%	+25.29%	+95.68%
SMLR Semler Scientific	0.00%	0.00%	0.00%	0.00%	-34.48%
STAA STAAR Surgical	0.00%	+9.56%	-4.71%	-19.14%	-17.33%
TNDM Tandem Diabetes Care	0.00%	+4.96%	-19.24%	+7.70%	+32.96%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BVS Bioventus	2.83	Moderate Buy	$16.80	27.95% Upside
SMLR Semler Scientific	2.00	Hold	N/A	N/A
STAA STAAR Surgical	2.08	Hold	$28.45	26.63% Upside
TNDM Tandem Diabetes Care	2.48	Hold	$29.13	76.56% Upside

Current Analyst Ratings Breakdown

Latest SMLR, BVS, TNDM, and STAA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/30/2026	TNDM Tandem Diabetes Care	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Neutral	$24.00 ➝ $20.00
9/29/2026	STAA STAAR Surgical	Veritas Investment Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$31.00
9/29/2026	STAA STAAR Surgical	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Buy	$28.00 ➝ $31.00
9/24/2026	TNDM Tandem Diabetes Care	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$31.00 ➝ $28.00
9/22/2026	STAA STAAR Surgical	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$28.00 ➝ $23.00
9/8/2026	TNDM Tandem Diabetes Care	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
9/2/2026	STAA STAAR Surgical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/21/2026	TNDM Tandem Diabetes Care	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Outperform
8/17/2026	STAA STAAR Surgical	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$28.00
8/17/2026	BVS Bioventus	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$15.00 ➝ $19.00
8/17/2026	BVS Bioventus	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$15.00

(Data available from 10/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BVS Bioventus	$568.09M	1.94	$1.27 per share	10.30	$2.76 per share	4.76
SMLR Semler Scientific	$36.96M	8.41	$4.48 per share	4.54	$24.90 per share	0.82
STAA STAAR Surgical	$239.44M	4.71	N/A	N/A	$6.92 per share	3.25
TNDM Tandem Diabetes Care	$1.01B	1.13	N/A	N/A	$2.29 per share	7.21

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BVS Bioventus	$22.73M	$0.77	17.05	14.75	1.67	9.36%	28.08%	9.82%	N/A
SMLR Semler Scientific	$40.90M	$2.78	7.31	N/A	N/A	130.80%	34.21%	25.58%	N/A
STAA STAAR Surgical	-$80.45M	$0.07	321.05	38.74	N/A	1.13%	9.05%	6.99%	11/4/2026 (Estimated)
TNDM Tandem Diabetes Care	-$204.71M	-$0.93	N/A	183.33	N/A	-6.08%	-45.97%	-6.23%	11/5/2026 (Estimated)

Latest SMLR, BVS, TNDM, and STAA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2026	Q2 2026	STAA STAAR Surgical	$0.2214	$0.39	+$0.1686	$0.16	$90.60 million	$93.54 million
8/6/2026	Q2 2026	TNDM Tandem Diabetes Care	-$0.3207	-$0.31	+$0.0107	-$0.31	$254.99 million	$254.56 million
8/5/2026	Q2 2026	BVS Bioventus	$0.22	$0.22	N/A	$0.47	N/A	$153.21 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BVS Bioventus	N/A	N/A	N/A	N/A	N/A
SMLR Semler Scientific	N/A	N/A	N/A	N/A	N/A
STAA STAAR Surgical	N/A	N/A	N/A	N/A	N/A
TNDM Tandem Diabetes Care	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BVS Bioventus	0.83	1.69	1.17
SMLR Semler Scientific	0.21	1.97	1.95
STAA STAAR Surgical	N/A	4.66	4.03
TNDM Tandem Diabetes Care	4.62	3.18	2.65

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BVS Bioventus	62.94%
SMLR Semler Scientific	49.37%
STAA STAAR Surgical	96.70%
TNDM Tandem Diabetes Care	N/A

Insider Ownership

Company	Insider Ownership
BVS Bioventus	33.50%
SMLR Semler Scientific	16.40%
STAA STAAR Surgical	39.90%
TNDM Tandem Diabetes Care	2.10%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BVS Bioventus	950	84.09 million	55.92 million	N/A
SMLR Semler Scientific	120	15.29 million	12.78 million	Not Optionable
STAA STAAR Surgical	957	50.14 million	30.14 million	Optionable
TNDM Tandem Diabetes Care	2,500	69.58 million	68.12 million	Optionable

SMLR, BVS, TNDM, and STAA Headlines

Recent News About These Companies

Citigroup Has Lowered Expectations for Tandem Diabetes Care (NASDAQ:TNDM) Stock Price

October 2 at 1:43 AM | americanbankingnews.com

Tandem Diabetes Care to Announce Third Quarter 2026 Financial Results on November 5, 2026

October 1 at 6:52 PM | finance.yahoo.com

Tandem Diabetes Care (TNDM) Is Up 7.2% After International Launch Of Mobi Insulin Pump System

October 1 at 8:45 AM | finance.yahoo.com

Citigroup Issues Pessimistic Forecast for Tandem Diabetes Care (NASDAQ:TNDM) Stock Price

September 30, 2026 | marketbeat.com

Financial Contrast: IRIDEX (NASDAQ:IRIX) and Tandem Diabetes Care (NASDAQ:TNDM)

September 30, 2026 | americanbankingnews.com

Tandem Diabetes Expands Insulin Delivery System to 12 New Countries

September 28, 2026 | finance.yahoo.com

Tandem Diabetes Care, Inc. Announces Tandem Mobi Automated Insulin Delivery System Is Now Available in Twelve International Markets

September 28, 2026 | marketscreener.comM

Tandem Diabetes expands Mobi insulin system overseas

September 28, 2026 | grafa.comG

Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets

September 28, 2026 | businesswire.com

Tandem Diabetes Care(TNDM)获机构维持买入评级，目标价下调至28美元

September 26, 2026 | eeo.com.cnE

Tandem Diabetes Care (NASDAQ:TNDM) Stock Falls 6.7% After Analyst Downgrade

September 26, 2026 | americanbankingnews.com

Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Target Cut by Truist Financial

September 26, 2026 | americanbankingnews.com

Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Down 6.7% After Analyst Downgrade

September 24, 2026 | marketbeat.com

Tandem Diabetes Care (NASDAQ:TNDM) Given New $28.00 Price Target at Truist Financial

September 24, 2026 | marketbeat.com

Truist Lowers Price Target on Tandem Diabetes Care to $28 From $31, Keeps Buy Rating

September 24, 2026 | marketscreener.comM

Is Tandem Diabetes Care (TNDM) Undervalued As Investors Weigh Its 34% One Year Return?

September 20, 2026 | finance.yahoo.com

Engineers Gate Manager LP Makes New Investment in Tandem Diabetes Care, Inc. $TNDM

September 20, 2026 | marketbeat.com

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Consensus Rating of "Hold" from Brokerages

September 18, 2026 | marketbeat.com

Tandem Diabetes Care (TNDM) Soars 7.7%: Is Further Upside Left in the Stock?

September 17, 2026 | zacks.com

Tandem Diabetes Care (NASDAQ:TNDM) Shares Up 5.6% - Should You Buy?

September 16, 2026 | marketbeat.com

Squarepoint Ops LLC Buys Shares of 217,386 Tandem Diabetes Care, Inc. $TNDM

September 13, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

SMLR, BVS, TNDM, and STAA Company Descriptions

Bioventus NASDAQ:BVS

$13.13 -0.32 (-2.38%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$13.14 +0.01 (+0.08%)

As of 10/2/2026 07:42 PM Eastern

Bioventus Inc. a medical device company, focuses on developing and commercializing clinically treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's portfolio of products includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions include bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies comprise an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.

Semler Scientific NASDAQ:SMLR

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.

STAAR Surgical NASDAQ:STAA

$22.47 +0.09 (+0.40%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$22.45 -0.02 (-0.09%)

As of 10/2/2026 07:30 PM Eastern

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Tandem Diabetes Care NASDAQ:TNDM

$16.50 0.00 (0.00%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$16.62 +0.12 (+0.72%)

As of 10/2/2026 07:30 PM Eastern

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SMLR, BVS, TNDM, and STAA Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SMLR, BVS, TNDM, and STAA Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SMLR, BVS, TNDM, and STAA Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

SMLR, BVS, TNDM, and STAA Company Descriptions

Bioventus NASDAQ:BVS

Semler Scientific NASDAQ:SMLR

STAAR Surgical NASDAQ:STAA

Tandem Diabetes Care NASDAQ:TNDM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SMLR, BVS, TNDM, and STAA Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SMLR, BVS, TNDM, and STAA Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SMLR, BVS, TNDM, and STAA Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

SMLR, BVS, TNDM, and STAA Company Descriptions

Bioventus NASDAQ:BVS

Semler Scientific NASDAQ:SMLR

STAAR Surgical NASDAQ:STAA

Tandem Diabetes Care NASDAQ:TNDM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools